Vimarsana
Biggest News Aggregation in the World

Page 4 - Agnetic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agnetic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agnetic Today - Breaking & Trending Today

New PET-MRI scanner at HUS's isotope unit brings significant benefits to patients - Vimarsana News

New PET-MRI scanner at HUS's isotope unit brings significant benefits to patients

Helsinki University Hospital's (HUS) Isotope Unit has unveiled a cutting-edge PET-MRI scanner that simultaneously performs PET imaging and magnetic resonance imaging (MRI). This dual-functionality is particularly advantageous for pediatric patients who require sedation during the procedure. Moreover, the new technology reduces the amount of radiation exposure patients receive.

Voyager 2 Gets a Life-Extending Power Boost in Deep Space - Vimarsana News

Voyager 2 Gets a Life-Extending Power Boost in Deep Space

Ramin Skibba NASA engineers have come up with a power-saving strategy to eke more time--and more science--out of the Voyager probes, humanity's longest-

MyJournals.org - Science - 'Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study' (BMC Surgery) - Vimarsana News

MyJournals.org - Science - 'Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study' (BMC Surgery)

MyJournals.org - Science - 'Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study' (BMC Surgery)

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD - Vimarsana News

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy following 24 weeks of treatment in patients... | June 13, 2023

Soft Magnetic Composites Market Sales Growth Will Drive Market Revenue Growth - Vimarsana News

Soft Magnetic Composites Market Sales Growth Will Drive Market Revenue Growth

Soft Magnetic Composites Market Sales Growth Will Drive Market Revenue Growth